Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 22 February 2023, 14:30 HKT/SGT
Share:
    

Source: Malaysian Genomics Resource Centre Bhd
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and overseas

PETALING JAYA, Malaysia, Feb 22, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Bhd, a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a strategic collaboration agreement with Divine Genes Sdn Bhd to collaborate on business opportunities in relation to the improvement and international distribution of genetic tests for reproductive health.

Sasha Nordin, Chief Executive Officer of Malaysian Genomics Resource Centre Berhad

Divine Genes is an investment holding company with businesses in pharmaceutical product distribution, financial consultancy services as well as general merchandise and trading.

Under the strategic collaboration, Divine Genes' genetic test for reproductive health will be added to Malaysian Genomics' genetic test portfolio, which will market and distribute these tests in Malaysia and overseas. Both parties will also cooperate in improving the product.

En. Sasha Nordin, Chief Executive Officer of Malaysian Genomics said, "Decreasing fertility and birth rates are common across the world, and demand for reproductive medicine is growing in many countries. This new, pioneering DNA-driven fertility test can help reproductive health specialists and their patients make important decisions in support of improving the outcome of fertility treatments. This test will form a critical part of Malaysian Genomics' genetic screening portfolio of over 550 tests available across Southeast Asia and the Middle East where we have a presence."

Dr. Pawel Suwinski, Director of Divine Genes said, "This is a good opportunity for us to work with an organisation with the market reach, track record and platform to distribute our test. This collaboration is a good platform for both parties to leverage on each other's strengths in improving the product and expanding the market for the test."

Malaysian Genomics Resource Centre Bhd: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/


Topic: New market for product
Source: Malaysian Genomics Resource Centre Bhd

Sectors: Daily Finance, Daily News, BioTech, Healthcare & Pharm, Local Biz
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Malaysian Genomics Resource Centre Bhd
Aug 29, 2023 13:00 HKT/SGT
Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals
May 15, 2023 18:00 HKT/SGT
Malaysian Genomics Inks Agreement in Expansion to Bangladesh
Feb 27, 2023 13:00 HKT/SGT
Malaysian Genomics to Boost Play on the Football Pitch
Feb 24, 2023 17:30 HKT/SGT
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
Feb 24, 2023 13:30 HKT/SGT
Malaysian Genomics to Collaborate on Cannabinoid R&D
Jan 9, 2023 14:00 HKT/SGT
Malaysian Genomics Explores R&D Collaboration with SIRIM
Nov 23, 2022 17:30 HKT/SGT
Malaysian Genomics Sees Rise in Profit Margins for 1Q
Oct 26, 2022 19:00 HKT/SGT
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE
Oct 12, 2022 13:00 HKT/SGT
Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities
Sept 23, 2022 14:00 HKT/SGT
Malaysian Genomics Grows Presence in Thailand
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: